Fungal biotransformation of tanshinone results in [4+2] cycloaddition with sorbicillinol: evidence for enzyme catalysis and increased antibacterial activity

Appl Microbiol Biotechnol. 2016 Oct;100(19):8349-57. doi: 10.1007/s00253-016-7488-6. Epub 2016 May 20.

Abstract

The biotransformation of tanshinone IIA to a new antibacterial agent tanshisorbicin (1) by the fungus Hypocrea sp. (AS 3.17108) is described. The structure of tanshisorbicin is a hybrid of tanshinone IIA (2) and sorbicillinol (3). The latter is a metabolite produced by Hypocrea sp. The structure of tanshisorbicin was determined using mass spectrometry, NMR spectroscopy, and ECD calculations. The anti-MRSA activity of 1 was found to be significantly higher than that of the parent substrate Tan IIA. Preliminary experiments indicate that tanshisorbicin is formed via a [4+2] cycloaddition reaction that is likely catalyzed by microbial enzyme.

Keywords: Biotransformation; Hypocrea sp; Tanshinone IIA; [4+2] cycloaddition reaction.

MeSH terms

  • Abietanes / metabolism*
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / metabolism*
  • Biotransformation
  • Cycloaddition Reaction
  • Cyclohexanones / chemistry
  • Cyclohexanones / metabolism*
  • Mass Spectrometry
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Microbial Sensitivity Tests
  • Models, Molecular
  • Molecular Structure
  • Trichoderma / metabolism*

Substances

  • Abietanes
  • Anti-Infective Agents
  • Cyclohexanones
  • sorbicillinol
  • tanshinone